胚系突变作为肺癌风险因素的系统综述与荟萃分析
该系统综述与荟萃分析纳入28项研究,评估肺癌患者中致病或可能致病胚系变异(P/LP PGVs)的患病率及基因分布。汇总患病率为7.9%(95%CI 3.8%-15.9%),以DNA损伤修复基因变异最常见;研究平均年龄较低和测序面板较大与患病率较高相关。
要点
- 肺癌患者P/LP胚系变异汇总患病率为7.9%,异质性高(I2=98.8%)。
- 常见基因患病率:BRCA2 0.96%、ATM 0.67%、TP53 0.57%、CHEK2 0.49%、BRCA1 0.48%、EGFR 0.17%。
- 研究平均年龄较低和测序面板较大与P/LP患病率较高相关。
核心结论
- 约8%的肺癌患者携带P/LP胚系变异,最常见于DNA损伤修复基因。
研究设计与样本
- 系统文献综述与随机效应模型荟萃分析,共纳入28项报告肺癌患者P/LP胚系变异患病率的研究。
主要发现
- P/LP胚系变异汇总患病率为7.9%(95%CI 3.8%-15.9%),异质性高(I2=98.8%)。
- 基因特异性患病率:BRCA2 0.96%、ATM 0.67%、TP53 0.57%、CHEK2 0.49%、BRCA1 0.48%、EGFR 0.17%。
- 高风险富集队列P/LP患病率更高,DNA损伤修复基因变异在非亚洲人群比东亚人群更常见(p<0.05)。
- 研究平均年龄较低与P/LP患病率较高相关(每增加1岁OR=0.91;p=0.024),测序面板较大亦相关(每对数增加OR=1.72;p=0.013)。
- 病例报告描述了超过15种罕见PGVs,最常涉及EGFR,尤其是EGFR T790M。
临床怎么用
- 支持对肺癌患者进行风险适配的遗传学评估,尤其关注年轻患者和DNA损伤修复基因。
局限性
- 汇总患病率异质性高(I2=98.8%),可能限制结论的稳健性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Inherited predispositions to lung cancer are increasingly recognized, but the prevalence and distribution of pathogenic germline variants (PGVs) remain incompletely characterized. METHODS: We performed a systematic literature review of studies reporting the prevalence of pathogenic or likely pathogenic (P/LP) germline variants in patients with lung cancer. Random-effects models pooled overall prevalence estimates and gene-specific frequencies for frequently reported genes (EGFR, BRCA1, BRCA2, ATM, CHEK2, and TP53). Subgroup analyses were performed according to cohort type and ancestry. Univariable meta-regression was used to evaluate associations between mean age and sequencing panel size with P/LP prevalence. Case reports and series were qualitatively summarized. RESULTS: A total of 28 studies were included in the meta-analysis. The pooled prevalence of P/LP PGVs was 7.9% (95% confidence interval: 3.8%-15.9%) with high heterogeneity (I2 = 98.8%). Gene-specific prevalence rates were as follows: BRCA2, 0.96%; ATM, 0.67%; TP53, 0.57%; CHEK2, 0.49%; BRCA1, 0.48%; and EGFR, 0.17%. The high-risk enriched cohort had a higher prevalence of P/LP PGVs, whereas variants in DNA damage repair genes were more frequent in non-Asian populations than in East Asians (p < 0.05). A higher PGV prevalence was associated with a lower study-level mean age (per-year odds ratio = 0.91 for increasing age; p = 0.024) and larger sequencing panels (per log increase in tested genes, odds ratio = 1.72; p = 0.013). Case reports described more than 15 rare PGVs, most frequently involving EGFR, particularly EGFR T790M. CONCLUSIONS: Approximately 8% of patients with lung cancer harbor P/LP germline variants, most commonly in DNA damage repair genes. A younger study-level mean age was associated with higher overall prevalence, whereas variants in several DNA damage repair genes were more frequent in non-Asian or mixed populations than in East Asian populations, supporting risk-adapted genetic evaluation.
引用
- Lee JY, Kim S, Na KJ, et al. Germline Mutations as Risk Factors for Lung Cancer: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2026. PMID: 42409116. doi:10.1016/j.jtho.2026.104069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。